Stay updated with breaking news from Nasdaq Cbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) was the recipient of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 251,800 shares, a decrease of 21.9% from the May 15th total of 322,400 shares. Based on an average trading volume of 226,900 shares, the days-to-cover ratio is […]
Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) saw a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 211,700 shares, a decrease of 16.0% from the April 15th total of 252,100 shares. Based on an average daily volume of 932,600 shares, the short-interest ratio is […]
Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 152,500 shares, a decline of 79.5% from the March 15th total of 743,100 shares. Based on an average daily volume of 1,420,000 shares, the […]
Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 743,100 shares, an increase of 274.7% from the February 28th total of 198,300 shares. Approximately 3.8% of the shares of the stock are short sold. Based on […]
Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 743,100 shares, a growth of 274.7% from the February 28th total of 198,300 shares. Approximately 3.8% of the company’s stock are short sold. Based on an average […]